Altimmune Correlations

ALT Stock  USD 4.09  0.58  16.52%   
The current 90-days correlation between Altimmune and DBV Technologies is -0.05 (i.e., Good diversification). The correlation of Altimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Altimmune Correlation With Market

Modest diversification

The correlation between Altimmune and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Altimmune and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.

Moving against Altimmune Stock

  0.73GE GE AerospacePairCorr
  0.56MSFT Microsoft Sell-off TrendPairCorr
  0.47HD Home DepotPairCorr
  0.39PG Procter GamblePairCorr
  0.38CVX Chevron CorpPairCorr
  0.34DOCKF Beyond Medical TechnPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LBRXANNX
AMRNKRRO
ANROANNX
LBRXDBVT
LBRXANRO
LRMRKRRO
  

High negative correlations

ANROAMRN
ANROKRRO
KRROANNX
AMRNANNX
LBRXAMRN
LBRXKRRO

Risk-Adjusted Indicators

There is a big difference between Altimmune Stock performing well and Altimmune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Altimmune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DBVT  4.46  1.00  0.22 (16.73) 3.68 
 16.55 
 36.36 
ANNX  3.73  0.88  0.23  1.00  3.19 
 10.28 
 35.10 
KRRO  5.82 (1.67) 0.00 (0.21) 0.00 
 12.19 
 91.55 
ENGN  5.67  0.81  0.17  0.41  4.90 
 14.00 
 61.40 
LRMR  3.86 (0.27) 0.00 (0.19) 0.00 
 8.72 
 29.05 
AURA  2.49 (0.38) 0.00 (0.09) 0.00 
 4.65 
 18.08 
AMRN  2.16 (0.37) 0.00 (0.22) 0.00 
 4.18 
 23.79 
ANRO  6.99  2.39  0.40  0.48  5.33 
 12.56 
 100.99 
LBRX  3.40  0.49  0.12  40.75  3.22 
 7.62 
 23.56 
ACIU  4.38  0.17  0.06  0.13  5.31 
 10.46 
 39.46 

Altimmune Corporate Management

Scot RobertsChief Scientific OfficerProfile
Richard MBAChief OfficerProfile
Andrew MSCorporate ControllerProfile
Raymond MBAChief OfficerProfile
Jos OchoaChief OfficerProfile
MBA MDChief OfficerProfile